Tag Archives: aspirin

Bayer and Death: A New Set of Questions about 1918

Part 5 of 5

By J. Holcombe, D. Jacobson, and T. Ruhl

Without question, the 20 to 50 million deaths during the 1918-19 “flu” epidemic represent the greatest iatrogenic catastrophe in human history.

The attribution of those deaths to a virulent new virus has been debunked by the National Institute of Allergy and Infectious Diseases, which said that common upper respiratory bacteria were responsible.  Aspirin, heavily marketed and medically recommended, suppressed the immune system and led to massive infection resulting in pneumonia and death.

The central role that aspirin played in those deaths contrasts sharply with the survival of those who avoided it in favor of natural treatments.  Aspirin, not a virus, created a pharmaceutical industry calamity.

Continue reading

Bayer and Death: Aspirin Deaths Continue Beyond 1918

Part 4 of 5

By J. Holcombe, D. Jacobson, and T. Ruhl

A confluence of events created a “perfect storm” for widespread salicylate toxicity. The loss of Bayer’s patent on aspirin in February 1917 allowed many manufacturers into the lucrative aspirin market. Official recommendations for aspirin therapy at toxic doses were preceded by ignorance of the unusual nonlinear kinetics of salicylate (unknown until the 1960s), which predispose to accumulation and toxicity; tins and bottles that contained no warnings and few instructions; and fear of “Spanish” influenza, an illness that had been spreading like wildfire.   ~ Dr. Karen Starko

Given the role that it played in the millions of 1918 deaths, a further look at aspirin is in order.

Bayer aspirin was one of the earliest of drugs from the pharmaceutical industry, dependent on the oil industry, and has become the most commonly used and trusted drug.  As such, it exemplifies the displacement of natural treatments by synthetic drugs.

Is Bayer aspirin safe today?

Continue reading